The stepwise approach to diabetes prevention: Results from the D-CLIP randomized controlled trial

Diabetes Care

Volumn 39, Issue 10, 2016, Pages 1760-1767

  Weber, Mary Beth ^a   Ranjani, Harish ^b   Staimez, Lisa R ^a   Anjana, Ranjit M ^b   Ali, Mohammed K ^a   Narayan, K M Venkat ^a   Mohan, Viswanathan ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTRITIS; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INDIA; INDIAN; ISOLATED IMPAIRED FASTING GLUCOSE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RASH; RISK ASSESSMENT; BODY MASS; CAUCASIAN; DIET; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; LIFESTYLE; METABOLISM; MIDDLE AGED; OVERWEIGHT; PREDIABETIC STATE; SOCIOECONOMICS;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS; DIET; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; INDIA; LIFE STYLE; MALE; METFORMIN; MIDDLE AGED; OBESITY; OVERWEIGHT; PREDIABETIC STATE; SOCIOECONOMIC FACTORS;

EID: 84988913126     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-1241     Document Type: Article

References (39)

1. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
2. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20: 537-544
3. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289-297
4. Lindstr öm J, Louheranta A, Mannelin M, et al.; Finnish Diabetes Prevention Study Group. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003;26: 3230-3236
5. Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: A Japanese trial in IGT males. Diabetes Res Clin Pract 2005;67:152-162
6. Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: A consensus on type 2 diabetes prevention. Diabet Med 2007;24:451-463
7. American Diabetes Association. Prevention or delay of type 2 diabetes. Sec. 5. In Standards of Medical Care in Diabetesd2015. Diabetes Care 2015;38(Suppl.):S31-S32
8. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium, International Diabetes Federation, 2015
9. Weber MB, Ranjani H, Meyers GC, Mohan V, Narayan KM. A model of translational research for diabetes prevention in low and middleincome countries: The Diabetes Community Lifestyle Improvement Program (D-CLIP) trial. Prim Care Diabetes 2012;6:3-9
10. Gujral UP, Pradeepa R, Weber MB, Narayan KM, Mohan V. Type 2 diabetes in South Asians: Similarities and differences with white Caucasian and other populations. Ann N Y Acad Sci 2013;1281:51-63
11. WeberMB, Oza-Frank R, Staimez LR, AliMK, Narayan KM. Type 2 diabetes in Asians: Prevalence, risk factors, and effectiveness of behavioral intervention at individual and population levels. Annu Rev Nutr 2012;32:417-439
12. Nakagami T, Qiao Q, Carstensen B, et al.; DECODE-DECODA Study Group. Age, body mass index and type 2 diabetes-associations modified by ethnicity. Diabetologia 2003;46: 1063-1070
13. Ramachandran A, Snehalatha C, Vijay V. Low risk threshold for acquired diabetogenic factors in Asian Indians. Diabetes Res Clin Pract 2004;65:189-195
14. Mohan V, Amutha A, Ranjani H, et al. Associations of β-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians. Diabetes Technol Ther 2013; 15:315-322
15. Staimez LR,WeberMB,RanjaniH, et al. Evidence of reduced β-cell function in Asian Indians with mild dysglycemia. Diabetes Care 2013;36:2772-2778
16. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163
17. American Diabetes Association. Classification and diagnosis of diabetes. Sec.2. In Standards of Medical Care in Diabetesd2015. Diabetes Care 2015;38(Suppl.):S8-S16
18. Ranjani H, Weber MB, Anjana RM, Lakshmi N, Narayan KM, Mohan V. Recruitment challenges in a diabetes prevention trial in a lowand middle-income setting. Diabetes Res Clin Pract 2015;110:51-59
19. Sudha V, Radhika G, Sathya RM, Ganesan A, Mohan V. Reproducibility and validity of an interviewer-administered semi-quantitative food frequency questionnaire to assess dietary intake of urban adults in southern India. Int J Food Sci Nutr 2006;57:481-493
20. Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:1343-1350
21. Saito T,WatanabeM, Nishida J, et al.; Zensharen Study for Prevention of Lifestyle Diseases Group. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: A randomized controlled trial. Arch Intern Med 2011;171:1352-1360
22. Anjana RM, Shanthi Rani CS, Deepa M, et al. Incidence of diabetes and prediabetes and predictors of progression among Asian Indians: 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care 2015;38:1441-1448
23. Viscogliosi G, Cipriani E, Liguori ML, et al. Mediterranean dietary pattern adherence: Associations with prediabetes, metabolic syndrome, and related microinflammation. Metab Syndr Relat Disord 2013;11:210-216
24. Duijzer G, Haveman-Nies A, Jansen SC, ter Beek J, Hiddink GJ, Feskens EJ. SLIMMER: A randomised controlled trial of diabetes prevention in Dutch primary health care: Design and methods for process, effect, and economic evaluation. BMC Public Health 2014;14:602
25. Marinik EL, Kelleher S, Savla J, Winett RA, Davy BM. The Resist Diabetes trial: Rationale, design, and methods of a hybrid efficacy/effectiveness intervention trial for resistance training maintenance to improve glucose homeostasis in older prediabetic adults. Contemp Clin Trials 2014; 37:19-32
26. UtzschneiderKM, Tong J, Montgomery B, et al. The dipeptidyl peptidase-4 inhibitor vildagliptin improves β-cell function and insulin sensitivity in subjects with impaired fasting glucose. Diabetes Care 2008;31:108-113
27. Amati F, Dubé JJ, CoenPM, Stefanovic-Racic M, Toledo FG, Goodpaster BH. Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes Care 2009;32:1547-1549
28. Nanditha A, Snehalatha C, Ram J, et al. Impact of lifestyle intervention in primary prevention of Type 2 diabetes did not differ by baseline age and BMI among Asian-Indian people with impaired glucose tolerance. Diabet Med. 16 January 2016 [Epub ahead of print]. DOI: 10.1111/dme.13071
29. Glechner A, Harreiter J, Gartlehner G, et al. Sex-specific differences in diabetes prevention: A systematic review and meta-analysis. Diabetologia 2015;58:242-254
30. Ranjani H, Weber MB, Anjana RM, Lakshmi N, Narayan KM, Mohan V. Recruitment challenges in a diabetes prevention trial in a lowand middle-income setting. Diabetes Res Clin Pract 2015;110:51-59
31. Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program?. Health Aff (Millwood) 2012;31:67-75
32. Fujimoto WY, Jablonski KA, Bray GA, et al.; Diabetes Prevention Program Research Group. Body size and shape changes and the risk of diabetes in the diabetes prevention program. Diabetes 2007;56:1680-1685
33. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999;84:137-144
34. Kouvelioti R, Vagenas G, Langley-Evans S. Effects of exercise and diet on weight loss maintenance in overweight and obese adults: A systematic review. J SportsMed Phys Fitness 2014;54:456-474
35. Lindström J, PeltonenM, Eriksson JG, et al.; Finnish Diabetes Prevention Study (DPS). Improved lifestyle and decreased diabetes risk over 13 years: Long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 2013;56:284-293
36. Anjana RM, Pradeepa R, Deepa M, et al.; ICMR-INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia 2011;54:3022-3027
37. Sentell TL, He G, Gregg EW, Schillinger D. Racial/ethnic variation in prevalence estimates for United States prediabetes under alternative 2010 American Diabetes Association criteria: 1988-2008. Ethn Dis 2012;22:451-458
38. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1263-1268
39. Weber MB, Harish R, Staimez LR, et al. Reduction in diabetes incidence differs by prediabetes type in a randomized translational trial of prevention (Abstract). Diabetes 2015;64(Suppl. 1):LB46